Page results
-
Details of the charity and voluntary sector services.
-
Details of the charity and voluntary sector services in Islington and surrounding areas.
-
Professor Karl Peggs was appointed to the Board in August 2024 as the director of research and director of the National Institute for Health and Care Research (NIHR) UCLH Biomedical Research Centre (BRC).
-
Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.
-
More than 400 patients at UCLH have so far benefited from an exciting new cancer treatment called proton beam therapy (PBT) – which uses high-energy beams of protons, rather than X-rays, to deliver a dose of radiotherapy.
-
Following the successful premiere at Everyman Cinema, Muswell Hill, SICKLE, the groundbreaking documentary on sickle cell disorder, continued its impactful journey with a screening at Ritzy Picture House in Brixton on Thursday 24 October. Held in celebration of Black History Month, the event aimed to raise awareness and educate both healthcare professionals and the public about the realities of living with sickle cell disorder.
-
Dr Hotton is a consultant neurologist with a special interest in movement disorders and the neurological care of patients with central nervous system tumours.
-
Photographs captured during the Black History Month screening on 24th October 2024.
-
UCLH has recruited the first patient to a global trial of an investigational medication for adults with Huntington’s Disease (HD).
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
File results
-
FOI/2023/0331 - Sexual assaults in hospitals from 2020 to 2023
-
FOI/2023/0292 - Spend on bank/ agency/ locum staff for junior doctor strike cover
-
FOI/2023/0299 - Trust Medical Examiner contact details
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022
-
FOI/2023/0340 - NHS charging of overseas visitors